Acadia Pharmaceuticals | ACAD - EPS Earnings Per Share


Acadia Pharmaceuticals reported $0.02 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 0.02 0.07 0.11 May/06
FY2025Q4 Dec/2025 1.60 0.14 0.86 Feb/25
FY2025Q3 Sep/2025 0.42 0.14 0.20 Nov/05
FY2025Q2 Jun/2025 0.16 0.15 0.20 Aug/06
FY2025Q1 Mar/2025 0.11 0.01 0.10 May/07




Eps Change Date
Acadia Pharmaceuticals USD 0.02 1.58 Mar/2026
ALKERMES USD -0.4 0.69 Mar/2026
Alnylam Pharmaceuticals USD 1.99 0.74 Mar/2026
Biogen USD 3.57 1.58 Mar/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Cara Therapeutics USD -0.59 4.45 Sep/2025
Corcept Therapeutics USD -0.3 0.5 Mar/2026
Cytokinetics USD -1.67 0.17 Mar/2026
Eisai JPY -11.53 72.47 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Incyte USD 1.81 0.01 Mar/2026
J&J USD 2.7 0.24 Mar/2026
Moderna USD -3.4 1.29 Mar/2026
Neurocrine Biosciences USD 1.94 0.06 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
Prothena USD 0.6 1.06 Mar/2026
PTC Therapeutics USD -0.03 1.64 Mar/2026
Sarepta Therapeutics USD 3.16 6.74 Mar/2026
Ultragenyx Pharmaceutical USD -1.84 0.55 Mar/2026
Vanda Pharmaceuticals USD -0.09 0 Dec/2024
Vertex Pharmaceuticals USD 4.47 0.56 Mar/2026